Trial NCT02201524

View at ClinicalTrials.gov 
Org. Study IDs: B7451005
Secondary IDs: JAK-1 FOR PSORIASIS

Last trial update was posted on 2016-10-05

MeSH Interventions

Abrocitinib

MeSH Conditions

Psoriasis

Other Conditions

Plaque Psoriasis

Stopping Reasons

Study terminated 26 June 2015 due to changes in the drug development portfolio. This study was not terminated for reasons of safety and/or efficacy

Limitations And Caveats

The study was terminated early due to changes in the prioritization of the drug development portfolio and the early termination was not safety related.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID